At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 64 enrolled
Drug / intervention
Paracetamol +caudal ropivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Intravenous Paracetamol Combination With Caudal Ropivacaine on Quality of Postoperative Recovery in Pediatric Patients Undergoing Hypospadias Repair.A Randomized Controlled Trial.
In Brief
A Phase 4 clinical trial evaluating Paracetamol +caudal ropivacaine and Placebo for Postoperative Analgesia. Completed, enrolled 64 participants across 1 site.
Detailed Summary
To investigate whether the addition of intravenous paracetamol with caudal ropivacaine leads to better quality of postoperative recovery in patients undergoing hypospadius repair than caudal ropivacaine alone. The quality of recovery will be judged by postoperative analgesia requirement and lesser agitation in the postoperative period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Analgesia
CountriesPakistan
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedDec 2018
Enrollment StartJan 2019
Primary CompletionApr 2022
Study CompletionMay 2022
TodayJul 2026
First PostedDec 20, 2018
Enrollment StartJan 31, 2019
Primary CompletionApr 30, 2022
Study CompletionMay 1, 2022
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 7.5 years ago
Interventions
Paracetamol +caudal ropivacainedrug
Paracetamol + Ropivacaine
Placebodrug
Caudal ropivacaine